Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
RAD-140 + MK-677 + YK-11 Value Pack
2008 in stock
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
This research value pack combines three synthetic compounds frequently studied together in selective receptor and growth signalling pathway research: RAD-140 (Testolone), a non-steroidal selective receptor modulator; MK-677 (Ibutamoren), studied for growth hormone secretagogue properties; and YK-11, studied for its proposed interactions with myostatin-related signalling pathways. Combined research models allow investigation into how selective receptor modulation, growth hormone secretagogue signalling, and myostatin pathway interactions may intersect within body composition and growth-related signalling research. Research applications include comparative selective receptor pathway studies, multi-compound growth signalling research, and experimental protocol design using all three compound classes.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
| Synonyms | RAD-140 + MK-677 + YK-11 Value Pack |
|---|---|
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What distinct research pathways does each compound in this value pack address?
RAD-140 is studied for non-steroidal selective receptor modulator activity at androgen receptor binding sites, MK-677 for growth hormone secretagogue properties via GHS-R1a receptor engagement and downstream IGF-1 axis signalling, and YK-11 for proposed interactions with myostatin-related signalling pathways. Combined research protocols allow investigators to examine how these three distinct mechanisms may interact within shared experimental models examining body composition and growth-related signalling.
What experimental models are used to study this combination's effects on growth-related signalling pathways?
Cell-based receptor binding assays for RAD-140, growth hormone and IGF-1 pathway signalling measurements for MK-677, and myostatin-related gene expression assays (such as follistatin and myostatin pathway markers in myoblast or muscle cell models) for YK-11 are standard methods for studying this three-compound combination, typically compared across single-compound and combined-compound treatment arms relative to vehicle controls.
How should researchers structure comparative protocols using this three-compound value pack?
Factorial or staggered experimental designs incorporating single-compound, paired-compound, and full three-compound treatment arms allow researchers to isolate the contribution of each compound and identify any combination-specific effects on selected receptor and growth signalling endpoints, a standard approach when studying multi-pathway compound combinations.
